Literature DB >> 4032134

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

O C Tablan, T L Chorba, D V Schidlow, J W White, K A Hardy, P H Gilligan, W M Morgan, L A Carson, W J Martone, J M Jason.   

Abstract

During the period of 1979 to 1983, 38 patients with cystic fibrosis (CF) at the CF center of St. Christopher's Hospital for Children in Pennsylvania developed respiratory tract colonization with Pseudomonas cepacia. Seventeen (45%) of the patients with colonization died. Yearly incidence rates of P. cepacia colonization fluctuated between 1.3% and 6.1%, suggesting an endemic phenomenon. Case-control studies showed that severe underlying CF, use of aminoglycosides, and having a sibling with CF and P. cepacia colonization were significant risk factors for P. cepacia colonization. Once colonized with P. cepacia, patients with CF were likely to be hospitalized longer (P = 0.008) and to die sooner (P = 0.0001) than control patients with CF. Environmental and microbiologic studies did not identify a common source or mode of transmission of P. cepacia among patients. The results of this investigation suggest that P. cepacia colonization of patients with CF was endemic in the hospital, occurred more frequently in those with severe disease, and was associated with adverse clinical outcome.

Entities:  

Mesh:

Year:  1985        PMID: 4032134     DOI: 10.1016/s0022-3476(85)80511-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  90 in total

Review 1.  Cystic fibrosis.

Authors:  P Robinson
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.

Authors:  M Hogardt; K Trebesius; A M Geiger; M Hornef; J Rosenecker; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  The effects of purified 25-kDa lipase from a clinical isolate of Pseudomonas cepacia in the lungs of rats.

Authors:  M K Lonon; D E Woods; D C Straus
Journal:  Curr Microbiol       Date:  1992-08       Impact factor: 2.188

Review 4.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

5.  Epidemiology of Pseudomonas cepacia in cystic fibrosis.

Authors: 
Journal:  Can J Infect Dis       Date:  1993-05

6.  Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson
Journal:  Can J Infect Dis       Date:  1994-03

7.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Intramural bladder-wall abscess: a late complication arising after a urethrocystoscopy?

Authors:  Hagen Loertzer; Sven Olaf Höhne; Rainer Finke; Paolo Fornara
Journal:  Pediatr Surg Int       Date:  2005-01-12       Impact factor: 1.827

9.  Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.

Authors:  G Y Larsen; T L Stull; J L Burns
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.